Teleflex Highlights Results of Study Involving Arrow PICC with Chlorag+ard Technology
Proquest LLC |
In its release,
The research, using the Arrow PICC with Chlorag+ard Technology, determined that this kind of Peripherally Inserted Central Catheter (PICC) was associated with a nearly nine-fold drop in the rate of Central Line-Associated Bloodstream Infections (CLABSIs). The peer- reviewed study was conducted at
The Company noted that the study was undertaken in part because the medical center's CLABSI rate had remained above the national benchmark, despite efforts to prevent these potentially deadly infections. Use of an antimicrobial catheter in such circumstances is recommended by the CDC and the
In the study, concurrent data was collected from 260 patients who received the Arrow PICC with Chlorag+ard Technology. That data was then compared to retrospective data for 257 patients who had only received unprotected PICCs during the previous year.
The results of the study showed a clear, positive impact from the Arrow PICC with Chlorag+ard Technology. The 257 subjects in the non- interventional group had eight CLABSIs and an infection rate of 4.18/ 1000 line days. The 260 subjects in the interventional group had only one CLABSI and an infection rate of 0.47 infections/1000 line days.
In addition, a financial analysis showed that the Arrow PICC with Chlorag+ard Technology reduced costs associated with CLABSIs.
Using the device enabled the hospital to avoid seven CLABSIs during the six-month study period. Conservatively assuming a treatment cost of
The study author was
"We are excited about the results of this important study," said
More information and complete details:
((Comments on this story may be sent to [email protected]))
Copyright: | (c) 2014 ProQuest Information and Learning Company; All Rights Reserved. |
Wordcount: | 501 |
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News